This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stanley H. Weiss, MD
Environmental Epidemiology Branch National Cancer Institute Bethesda, Md

Harold M. Ginzburg, MD
National Institute on Drug Abuse Rockville, Md

JAMA. 1986;255(10):1289.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Cohen and associates, in their accompanying letter, have collected WBC counts on more than 11,000 adult inmates of a division of the New York City jail and determined that approximately 2.5% were leukopenic. This is certainly consistent with our historical data.¹ They have also determined that less than 10% of those who were leukopenic were also anergic. All 22 anergic inmates had a history of parenteral drug abuse. No data on human T-cell lymphotropic virus type III (HTLV-III) antibody appear to be available.

Leukopenia, per se, does not seem to be predictive of anergy or other prodromal signs and symptoms associated with AIDS. The development of testing procedures for HTLV-III antibody permits identification of those who have been exposed to the virus associated with AIDS, of whom only a portion are either prodromal or overtly ill.² Antibodies against HTLV-I, HTLV-II, and HTLV-III are prevalent among intravenous . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?